483 QuVa Pharma Jun 2017

483 QuVa Pharma Jun 2017

Shatina Alridge FDA, Jason Caballero FDA$119.00 - Available Now

FDA investigators audited the QuVa Pharma - Sugar Land, TX, United States facility and issued 1 inspectional observation (via FDA 483) on 02 Jun 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 02 Jun 2017
  • Location: Sugar Land, United States
  • FEI: 3012053582
Add To Cart